Jordan Liebman

Jordan Liebman

Auto-generated profile, based on publicly available information

Jordan Liebman

Department of Medicine NYU Grossman School of Medicine New York New York USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
ALAriane Lewis
Ariane Lewis
JLJordan Liebman
Jordan Liebman
ABAzza Bakkar
Azza Bakkar
EKElana Kreiger-Benson
Elana Kreiger-Benson
AKAndrew Kumpfbeck
Andrew Kumpfbeck
DGDavid Greer
David Greer
Lewis A, et al. J Clin Neurol. 2020 Jul;16(3):480-490. https://doi.org/10.3988/jcn.2020.16.3.480

24 July 2025 in Journal of Medical Ethics
Verified
Journal Article
Closed access
PDF file
JLJordan Liebman
Jordan Liebman
BPBrendan Parent
Brendan Parent
Normothermic regional perfusion during controlled donation after circulatory death has emerged as a means to increase the number and viability of organs available for transplant. Because normothermic regional perfusion uses extracorporeal membrane oxygenation, an intervention used for resuscitation under other circumstances, critics have concluded that organ donation using normothermic regional perfusion violates the dead donor rule. As such, the debate about normothermic regional perfusion has been framed as a binary choice between normothermic regional perfusion and the dead donor rule. In this paper, I argue that we should resist this binary framework and instead judge the permissibility of normothermic regional perfusion based on whether it harms organ donors. The obligations owed to organ donors derive from their moral status and include the obligation to prevent harm to donors, protect futures of value and satisfy donors’ critical interests. When performed correctly, normothermic regional perfusion does not violate these moral obligations. Therefore, normothermic regional perfusion does not harm organ donors during controlled donation after circulatory death, making it ethically permissible when performed in accordance with standardised protocols.

13 August 2022 in CASE
Verified
Journal Article
Open access
JLJordan Liebman
Jordan Liebman
DBDaniel Bamira
Daniel Bamira
RRRichard Ro
Richard Ro
AVAlan F. Vainrib
Alan F. Vainrib
ASAdam J. Small
Adam J. Small
MSMuhamed Saric
Muhamed Saric
• Abnormal fetal development can produce several anomalies of the caval venous system. • We present multimodality imaging of the most common caval venous anomalies. • Each imaging modality provides incremental value when identifying these anomalies. • Even normal variants may impact pacing lead or central venous catheter placement. • Pathologic variants may lead to intracardiac shunting.

6 July 2026 in Xenotransplantation
Verified
Journal Article
Closed access
PDF file
JLJordan Liebman
Jordan Liebman
AZAmanda Zink
Amanda Zink
TKTia Ketsan
Tia Ketsan
SKSamantha Klitenic
Samantha Klitenic
LPLuz Padilla
Luz Padilla
LKLaura L. Kimberly
Laura L. Kimberly

28 January 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
JLJordan Liebman
Jordan Liebman
EMEmily C McQuade
Emily C McQuade
SHSyed Hussain
Syed Hussain
MWMathew Williams
Mathew Williams
CPChristina A Penfield
Christina A Penfield
ASAdam Small
Adam Small
Background: Although infective endocarditis during pregnancy is rare, it carries significant morbidity and mortality for both mother and foetus. While professional societies provide recommendations for the treatment of infective endocarditis, there are no specific guidelines for the management of pregnancy-associated infective endocarditis. In this report, we present two cases of infective endocarditis presenting during the second trimester of pregnancy that required surgical intervention, focusing on the unique considerations when caring for pregnant individuals. Case summaries: Two patients in the second trimester of pregnancy presented with fevers and malaise. Both were found to have positive blood cultures and mitral valve vegetations, leading to diagnoses of mitral valve endocarditis. Their hospital courses were complicated by embolic strokes, and one patient required transcatheter embolization of a mycotic aneurysm. Both patients underwent surgical valve replacements with bioprosthetic valves. Ultimately, both patients delivered at term without complication. Discussion: In addition to the standard management of infective endocarditis, pregnancy-associated infective endocarditis requires multidisciplinary collaboration regarding the relative timing of cardiac surgery and delivery, the use of intraoperative foetal monitoring, and the choice of valve replacement and anticoagulation. Each of these decisions requires balancing the risk of morbidity and mortality to the patient, the risk of neonatal prematurity and associated complications and disability, and the risk of foetal death during cardiopulmonary bypass. We discuss our teams’ decision-making processes with a focus on the relevant considerations for each of these challenging decisions.